Inventor · disambiguated record
Bao-Lu Chen
Also filed as: CHEN BAO-LU
18 granted patents·10 pending applications·440 citations·filing 1996–2014
95Inventor score
Top patents by PatentIndex Score
28 records- 0198US6525102B1Stabilized liquid polypeptide-containing pharmaceutical compositionsCHIRON CORP·Filed 2000·Granted Feb 25, 2003·148 cites·58 claims
- 0295US7371373B2HSA-free formulations of interferon-βNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted May 13, 2008·50 cites·25 claims
- 0394US8277810B2Antagonist anti-CD40 antibodiesLONG LI·Filed 2007·Granted Oct 2, 2012·54 cites·50 claims
- 0494US7807142B2Stabilized liquid polypeptide-containing pharmaceutical compositionsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Oct 5, 2010·24 cites·21 claims
- 0589US6887462B2HSA-free formulations of interferon-betaCHIRON CORP·Filed 2001·Granted May 3, 2005·30 cites·113 claims
- 0685US8945564B2Antagonist anti-CD40 antibody pharmaceutical compositionsLU XIAOFENG·Filed 2007·Granted Feb 3, 2015·15 cites·37 claims
- 0785US7973136B2Optimized anti-CD30 antibodiesXENCOR INC·Filed 2006·Granted Jul 5, 2011·7 cites·8 claims
- 0883US7399463B2HSA-free formulations of interferon-betaNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Jul 15, 2008·13 cites·26 claims
- 0983US7030086B2Stabilized liquid polypeptide-containing pharmaceutical compositionsCHIRON CORP·Filed 2002·Granted Apr 18, 2006·13 cites·46 claims
- 1082US9574006B2Optimized anti-CD30 antibodiesLAZAR GREGORY ALAN·Filed 2011·Granted Feb 21, 2017·5 cites·9 claims
- 1178US7892531B2HSA-free formulations of interferon-βNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted Feb 22, 2011·2 cites·7 claims
- 1277US6323326B1Method of solubilizing, purifying, and refolding proteinCHIRON CORP·Filed 1996·Granted Nov 27, 2001·31 cites·69 claims
- 1377US5888968ATFPI formulationCHIRON CORP·Filed 1996·Granted Mar 30, 1999·31 cites·14 claims
- 1475US7226757B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Granted Jun 5, 2007·1 cites·31 claims
- 1565US6319896B1Method of solubilizing, purifying, and refolding proteinCHIRON CORP·Filed 1999·Granted Nov 20, 2001·15 cites·24 claims
- 1665US2007166309A1Optimized anti-cd30 antibodiesXENCOR INC·Filed 2007·Application pending·0 cites
- 1764US2007148171A1Optimized anti-CD30 antibodiesXENCOR INC·Filed 2006·Application pending·0 cites
- 1862US2006159679A1Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variantsCHIRON CORP·Filed 2006·Application pending·0 cites
- 1961US7022672B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorSEARLE LLC·Filed 2001·Granted Apr 4, 2006·1 cites·85 claims
- 2060US2004180827A1Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variantsCHIRON CORP·Filed 2004·Application pending·0 cites
- 2159US2008281084A1Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway InhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 2258US2003198602A1Methods for pulmonary delivery of interleukin-2CHIRON CORP·Filed 2003·Application pending·0 cites
- 2356US7659248B2Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteinsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Feb 9, 2010·0 cites·24 claims
- 2455US2008003294A1Methods for pulmonary delivery of interleukin-2NOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 2552US2004224886A1Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteinsCHIRON CORP·Filed 2004·Application pending·0 cites
- 2652US2015110783A1Antagonist anti-cd40 antibody pharmaceutical compositionsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 2750US8333958B2HSA-free formulations of interferon-BetaSHIRLEY BRET A·Filed 2011·Granted Dec 18, 2012·0 cites·43 claims
- 2846US2008057070A1Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their UseCHIRON CORP·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bao-Lu Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →